Clinical Trial: THCV Lowers Blood Sugar Levels In Type 2 Diabetics

Clinical Trials: THCV and Type 2 Diabetes

UNITED KINGDOM: The administration of THCV (tetrahydrocannabivarin), a non-psychoactive component of cannabis, is positively associated with glycemic control in type 2 diabetics, according to the randomized, placebo-controlled data published in the journal Diabetes Care. Investigators from the University of Nottingham, School of Medicine assessed the twice daily administration of various cannabinoids (CBD or THCV or CBD and THCV in Read the full article…

NORML Responds To National Academy of Sciences’ Marijuana Report

"Most patients in the pain groups reported replacing prescription medications with medicinal cannabis, the most common of which were opiates/opioids across all patient groups," authors concluded.

DISTRICT OF COLUMBIA: The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under Read the full article…

New Mexico Medical Cannabis Sales Exceed $50.6 Million In 2016

mmj

NEW MEXICO: The Medical Cannabis Program’s total industry revenues from 2015 to 2016 increased by $19.7 million, resulting in $50,638,520 and a growth of 64 percent. Cannabis sales significantly surpassed other notable industries. Comparatively, the New Mexico chile crop was valued at $41.1 million in 2015 and the state’s craft beer industry is expected to generate $30 million in 2016. The last reported Read the full article…

Medical Marijuana NY-Based Biotech Company Enters Clinical Trials

Controlled-release hemp oil CBD chewing gum and matching placebo gums will be tested for the clinical studies

NEW YORK:  AXIM Biotechnologies, Inc., a world leader in cannabinoid research and development, has entered clinical trials on treating irritable bowel syndrome (IBS) with the Company’s CanChew Plus cannabidiol (CBD) gum at Wageningen University in the Netherlands. Human Clinical Trials Detail Include: Controlled-release hemp oil CBD chewing gum and matching placebo gums will be tested for the Read the full article…

Health Insurers Won’t Cover Medical Marijuana In North Dakota

Health Insurers Just Say No to MMJ in ND

NORTH DAKOTA: North Dakota voters overwhelmingly approved the legalization of medical marijuana, and lawmakers are grappling with launching the program. But patients are about to learn that legalization does not mean insurance will cover the cost. Major health insurers in North Dakota have said they will not provide coverage for medical marijuana, which voters approved in Read the full article…

Canadian Producer Aphria Comments On News Of Pesticide Use; Reaffirms Commitment To Quality And Safety

Canadian producer Aphira affirms non-pesticide use

CANADA: Despite most Licensed Producers taking great care to provide safe and effective products, there are still reports surfacing regarding the presence of harmful pesticides in regulated medical cannabis. “We support the use of independent evaluations and testing of medical cannabis as a necessary measure to protect the safety of Canadians,” said Vic Neufeld, Chief Executive Read the full article…

Terra Tech Announces Opening Of Fourth Nevada Medical Cannabis Dispensary

Blum Dispensary

Grand Opening in Reno, Nevada on January 12, 2017 NEVADA: Terra Tech Corp., a vertically integrated cannabis-focused agriculture company,  announced that its new Blüm dispensary, located at 1085 South Virginia Street, Reno, Nevada, will open to patients on Monday, January 2nd, 2017 at 9:00 AM Pacific Time. The Company will also host a Grand Opening Read the full article…

Pennsylvania Department Of Health Provides Update On Medical Marijuana Program Implementation

"We cannot underestimate the role of physicians in making sure that patients can access medical marijuana," Secretary Murphy said.

PENNSYLVANIA:  At her regular briefing of the status of Pennsylvania’s Medical Marijuana Program, Secretary of Health Dr. Karen Murphy today announced applications for medical marijuana grower/processors and dispensaries will be available beginning January 17, 2017. Permit applications will be accepted from February 20, 2017 until March 20, 2017. “I am excited to announce that we’ve reached an important milestone in the program with Read the full article…

Study: Medical Cannabis Associated With Improved Cognitive Performance, Reduced Opioid Use

Michigan likes its marijuana

MASSACHUSETTS: Medical cannabis administration is associated with improved cognitive performance and lower levels of prescription drug use, according to longitudinal data published online in the journal Frontiers in Pharmacology. Investigators from Harvard Medical School, Tufts University, and McLean Hospital evaluated the use of medicinal cannabis on patients’ cognitive performance over a three-month period. Participants in the study were either Read the full article…

Citing Themselves as a Top Factor in Prescribed Opioid Abuse, 73% of US Physicians Want More Alternative Therapies And Less Meds

Doctors seek alternatives to opioids

MASSACHUSETTS: US physicians who prescribe opioid pain medications are owning their role in today’s opioid abuse while citing structural problems that feed the issue, and calling for more alternative therapies integrated with medication. The data are from the latest public health perception analysis created by InCrowd, a provider of real-time market intelligence to the life sciences and Read the full article…